We work throughout the year to propose and endorse quality guidelines to our members and the global professional community. Below is a list of guidance documents that are currently under development. Dive deeper into the details of each guidance document and follow the evolution of their progress via the links provided.
The status of each project is defined based on the steps of the GIN-McMaster Guideline Development Checklist available here.
|
Title |
Chair |
Approval Date |
Status |
Website |
|---|---|---|---|---|
|
Approach to suspected antibiotic allergy |
Mark de Boer, Netherlands |
January 2023 |
Data extraction (Completed) |
|
|
Vaccination of the immunocompromised host |
Olivier Epaulard, France |
January 2023 |
Data extraction (Ongoing) |
|
|
Dosing of antimicrobials in patient with renal impairment with or without RRT |
Thomas Tängdén, Sweden |
January 2023 |
Screening of literature (Ongoing) |
|
|
OPENING Project: IncOrPorating Ethics iN ClINical Guidelines: Practical Indications |
Elda Righi, Italy |
October 2022 |
Summarising evidence and conclusions (Ongoing) |
|
|
ESCMID Consensus document for management of COVID-19 in immunocompromised patients |
Michele Bartoletti, Italy and Roy Chemaly, United States |
May 2022 |
Summarising evidence and conclusions (Ongoing) |
|
|
Update of the 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients |
Evelina Tacconelli, Italy |
December 2020 |
Screening of literature (Ongoing) |
|
|
Antibiotic surgical prophylaxis regimens among patients colonised by MDR-GPB |
Nico T. Mutters, Germany |
December 2019 |
Reporting and Peer Review (Ongoing) |
|
|
Antimicrobial stewardship in the emergency department |
Jeroen Schouten, Netherlands |
December 2019 |
Reporting and Peer Review (March 2024) |
|
|
Influenza management and treatment |
Barbara Rath, France |
December 2019 |
Data extraction (March 2024) |
|
|
Microbiological diagnosis of bloodstream infections (ESCMID/ESA) |
Brigitte Lamy, France |
November 2018 |
Developing Recommendations and Determining their Strength (EtDs) (March 2024) |
|
|
Management of uncomplicated urinary tract infections (IDSA/ESCMID) |
Angela Huttner, Switzerland (ESCMID representative) |
April 2018 |
Reporting and peer review (March 2024) |
|
|
Diagnosis and management of infective encephalitis (ESCMID/EAN) |
Thomas Whitfield, United States (ESCMID representative) |
April 2018 |
Data extraction/quality assessment (April 2023) |
|
|
Management of Staphylococcus aureus bacteremia (IDSA/ESCMID) |
Winfried Kern, Germany and François Vandenesch, France |
January 2017 |
Developing Recommendations and Determining their Strength (EtDs) (March 2024) |
|
The draft document "ESCMID/EUCIC clinical guidelines on preoperative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery" is now available for public consultation.
ESCMID members whishing to participate should contact us (link to contact form here) indicating their ESCMID membership number and the title of the document they would like to review.
By accepting to participate to the public consultation, you agree to commit to confidentiality (you are not allowed to disclose the content and/or share the manuscript) and to respond within the deadline.
We will send you the confidential manuscript together with the form to provide feedback (Please comment on substantive content only, not editorial concerns).
You will also be asked to complete the AGREE GLOBAL RATING SCALE form to be completed (More information about the AGREE II tool can be found here).
The deadline to provide feedback is 11 June 2024.